FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007394927> ?p ?o ?g. }

• W3007394927 endingPage "69" @default.
• W3007394927 startingPage "63" @default.
• W3007394927 abstract "There is sufficient evidence to show the mortality reduction effect of colorectal cancer (CRC) screening programs using the fecal occult blood test (FOBT). However, we see cases that are found to be advanced CRC despite yearly FOBT screening.The aim of this study was to investigate the characteristics of advanced CRC detected by a fecal immunochemical test (FIT) screening program in participants with a negative screening result the previous year, which we call Negative advanced CRC. A total of 109,639 participants (10.0% required colonoscopy, of whom 76.9% received one) underwent a CRC screening program using a FIT from fiscal 2009 to 2017. Negative advanced CRC was compared with advanced CRC (First advanced CRC) found at the first visit in a person who had not had a FIT screening history for more than 3 years. In addition, we compared the characteristics of Negative advanced CRC with those of interval cancer: cancer cases detected after a negative screening result and before the date of the next recommended screening.A total of 339 cases of CRC (175 male: 164 female, 173 early stage: 166 advanced stage) were detected in the nine-year CRC screening period. The rate of right-sided CRCs was significantly higher in female (P < 0.01), advanced stage (P < 0.01), negative result previous year (P < 0.01), and symptom-negative (P < 0.01) participants than in each counterpart, respectively. The ratio of female (22/35; 62.9%) patients in Negative advanced CRCs tended to be high compared with that (40/83; 48.2%) in First advanced CRCs (P = 0.145). Overall, 22 (62.9%) of 35 Negative advanced CRCs and 28 (33.7%) of 83 First advanced CRCs were located in the right-sided colon, and the rate was significantly higher in Negative advanced CRCs (P < 0.01). In addition, the frequency of female patients was significantly higher in right-sided Negative advanced CRCs than in right-sided First advanced CRCs (P = 0.03).The characteristics of Negative advanced CRC cases (female and right-sided colon) were similar to those of interval cancer reported so far. In the future, it will be necessary to introduce a screening program that is highly sensitive to right-sided CRC." @default.
• W3007394927 created "2020-03-06" @default.
• W3007394927 creator A5000801676 @default.
• W3007394927 creator A5010283555 @default.
• W3007394927 creator A5025153031 @default.
• W3007394927 creator A5027091742 @default.
• W3007394927 creator A5055774688 @default.
• W3007394927 creator A5080407395 @default.
• W3007394927 creator A5083934369 @default.
• W3007394927 date "2020-01-01" @default.
• W3007394927 modified "2023-10-11" @default.
• W3007394927 title "Characteristics of Advanced Colorectal Cancer Detected by Fecal Immunochemical Test Screening in Participants with a Negative Result the Previous Year" @default.
• W3007394927 cites W1963603849 @default.
• W3007394927 cites W1968634260 @default.
• W3007394927 cites W1974809315 @default.
• W3007394927 cites W1993123486 @default.
• W3007394927 cites W2020769504 @default.
• W3007394927 cites W2030790825 @default.
• W3007394927 cites W2035228181 @default.
• W3007394927 cites W2042585974 @default.
• W3007394927 cites W2042986451 @default.
• W3007394927 cites W2049221197 @default.
• W3007394927 cites W2053271805 @default.
• W3007394927 cites W2058880693 @default.
• W3007394927 cites W2067550979 @default.
• W3007394927 cites W2079707364 @default.
• W3007394927 cites W2080971579 @default.
• W3007394927 cites W2094274486 @default.
• W3007394927 cites W2118256990 @default.
• W3007394927 cites W2124755543 @default.
• W3007394927 cites W2133538398 @default.
• W3007394927 cites W2134997723 @default.
• W3007394927 cites W2147183147 @default.
• W3007394927 cites W2152352469 @default.
• W3007394927 cites W2155252727 @default.
• W3007394927 cites W2161185314 @default.
• W3007394927 cites W2163696938 @default.
• W3007394927 cites W2170674763 @default.
• W3007394927 cites W2252618625 @default.
• W3007394927 cites W2265133561 @default.
• W3007394927 cites W2283507024 @default.
• W3007394927 cites W2316839116 @default.
• W3007394927 cites W2333024423 @default.
• W3007394927 cites W2334476518 @default.
• W3007394927 cites W2502347551 @default.
• W3007394927 cites W2530571203 @default.
• W3007394927 cites W2584662705 @default.
• W3007394927 cites W2610540587 @default.
• W3007394927 cites W2781525129 @default.
• W3007394927 cites W2895058884 @default.
• W3007394927 cites W2947893648 @default.
• W3007394927 cites W4232914880 @default.
• W3007394927 cites W4300420562 @default.
• W3007394927 doi "https://doi.org/10.33160/yam.2020.02.009" @default.
• W3007394927 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7028528" @default.
• W3007394927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32158335" @default.
• W3007394927 hasPublicationYear "2020" @default.
• W3007394927 type Work @default.
• W3007394927 sameAs 3007394927 @default.
• W3007394927 citedByCount "4" @default.
• W3007394927 countsByYear W30073949272021 @default.
• W3007394927 countsByYear W30073949272022 @default.
• W3007394927 countsByYear W30073949272023 @default.
• W3007394927 crossrefType "journal-article" @default.
• W3007394927 hasAuthorship W3007394927A5000801676 @default.
• W3007394927 hasAuthorship W3007394927A5010283555 @default.
• W3007394927 hasAuthorship W3007394927A5025153031 @default.
• W3007394927 hasAuthorship W3007394927A5027091742 @default.
• W3007394927 hasAuthorship W3007394927A5055774688 @default.
• W3007394927 hasAuthorship W3007394927A5080407395 @default.
• W3007394927 hasAuthorship W3007394927A5083934369 @default.
• W3007394927 hasBestOaLocation W30073949271 @default.
• W3007394927 hasConcept C121608353 @default.
• W3007394927 hasConcept C126322002 @default.
• W3007394927 hasConcept C143998085 @default.
• W3007394927 hasConcept C146357865 @default.
• W3007394927 hasConcept C151730666 @default.
• W3007394927 hasConcept C2776463041 @default.
• W3007394927 hasConcept C2778435480 @default.
• W3007394927 hasConcept C2779158730 @default.
• W3007394927 hasConcept C2993160541 @default.
• W3007394927 hasConcept C526805850 @default.
• W3007394927 hasConcept C71924100 @default.
• W3007394927 hasConcept C86803240 @default.
• W3007394927 hasConcept C90924648 @default.
• W3007394927 hasConceptScore W3007394927C121608353 @default.
• W3007394927 hasConceptScore W3007394927C126322002 @default.
• W3007394927 hasConceptScore W3007394927C143998085 @default.
• W3007394927 hasConceptScore W3007394927C146357865 @default.
• W3007394927 hasConceptScore W3007394927C151730666 @default.
• W3007394927 hasConceptScore W3007394927C2776463041 @default.
• W3007394927 hasConceptScore W3007394927C2778435480 @default.
• W3007394927 hasConceptScore W3007394927C2779158730 @default.
• W3007394927 hasConceptScore W3007394927C2993160541 @default.
• W3007394927 hasConceptScore W3007394927C526805850 @default.
• W3007394927 hasConceptScore W3007394927C71924100 @default.
• W3007394927 hasConceptScore W3007394927C86803240 @default.
• W3007394927 hasConceptScore W3007394927C90924648 @default.

• next